HomeBCLI • NASDAQ
add
Brainstorm Cell Therapeutics Inc
Previous close
$0.91
Day range
$0.75 - $0.90
Year range
$0.75 - $10.05
Market cap
4.99M USD
Avg Volume
231.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.19M | -33.62% |
Net income | -2.97M | 46.70% |
Net profit margin | — | — |
Earnings per share | -0.51 | 66.00% |
EBITDA | -3.14M | 33.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.00K | -85.62% |
Total assets | 1.83M | -56.46% |
Total liabilities | 9.60M | 5.85% |
Total equity | -7.76M | — |
Shares outstanding | 6.52M | — |
Price to book | -0.72 | — |
Return on assets | -413.40% | — |
Return on capital | 133.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.97M | 46.70% |
Cash from operations | -1.05M | 68.10% |
Cash from investing | 12.00K | -93.88% |
Cash from financing | 1.06M | -68.44% |
Net change in cash | 22.00K | -91.63% |
Free cash flow | -158.38K | 89.66% |
About
Founded
2000
Website
Employees
27
